financetom
Business
financetom
/
Business
/
US Supreme Court rejects medical marijuana firm's bid to avoid racketeering suit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Supreme Court rejects medical marijuana firm's bid to avoid racketeering suit
Apr 2, 2025 7:46 AM

WASHINGTON (Reuters) -The U.S. Supreme Court ruled on Wednesday against Medical Marijuana Inc ( MJNA ) in its bid to fend off a lawsuit by a commercial truck driver who was fired for failing a drug test after taking cannabidiol, or CBD, that he said was falsely sold as lacking the psychoactive ingredient present in marijuana.

The justices, in a 5-4 decision authored by conservative Justice Amy Coney Barrett, upheld a lower court's ruling that had allowed plaintiff Douglas Horn to bring a civil lawsuit against the San Diego-based company under the Racketeer Influenced and Corrupt Organizations Act.

This 1970 federal law, known as RICO, was designed to crack down on organized crime and its economic impact.

The RICO law's civil provisions permit triple damages for successful lawsuits by "any person injured in his business or property" as a result of certain actions by a defendant. At issue in the case was whether Horn's loss of employment was the kind of business injury Congress meant to guard against when it enacted the law.

"Medical Marijuana ( MJNA ) is left fighting the most natural interpretation of the text - that 'injured' means 'harmed' - with no plausible alternative in hand. That is a battle it cannot win," Barrett wrote in the ruling.

Horn, who was ailing from injuries sustained in a trucking accident, in 2012 purchased a CBD tincture called Dixie X. It was advertised as a natural pain reliever containing no tetrahydrocannabinol (THC), the psychoactive ingredient in marijuana that causes a high.

After a random drug test ordered by his employer detected THC in his system, Horn was fired from his trucking job that he had held for more than a decade. Horn has said he is not a marijuana user.

Horn and his wife, Cindy, in 2015 brought a lawsuit in federal court in New York state seeking monetary damages, claiming, among other things, that Medical Marijuana ( MJNA ) and associated companies violated the RICO Act's provisions. Horn had the tincture independently tested in a laboratory, which confirmed that the product contained THC.

According to the suit, a "pattern of racketeering activity" by the companies - including violations of the federal Controlled Substances Act, as well as mail fraud and wire fraud - inflicted a business or property injury on Horn in the form of his firing.

A federal trial judge ruled against Horn's civil RICO claim. The New York-based 2nd U.S. Circuit Court of Appeals reversed the judge's decision, prompting Medical Marijuana's ( MJNA ) appeal to the Supreme Court.

The Supreme Court heard arguments in the case on Oct. 15.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Primaris REIT Details $69.6 Million Treasury and Secondary Unit Offering
Primaris REIT Details $69.6 Million Treasury and Secondary Unit Offering
Oct 2, 2024
04:33 PM EDT, 10/02/2024 (MT Newswires) -- Primaris Real Estate Investment Trust (PMZ-UN.TO) and Canada Pension Plan Investment Board (CPPIB) after trade Wednesday entered into an agreement with a syndicate of underwriters who will purchase, on a bought-deal basis, an aggregate of 4.47 million units of Primaris at a price of $15.55 each. The offering consists of a treasury offering...
Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment
Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment
Oct 2, 2024
04:37 PM EDT, 10/02/2024 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Wednesday it is collaborating with AstraZeneca ( AZN ) in a clinical trial to evaluate a combination of casdatifan with volrustomig to treat patients with clear cell renal cell carcinoma. Casdatifan is Arcus's investigational and volrustomig is AstraZeneca's ( AZN ) investigational PD-1/CTLA-4 bispecific antibody. This is...
Fidelity National Financial Acquires First Nationwide Title Agency
Fidelity National Financial Acquires First Nationwide Title Agency
Oct 2, 2024
04:33 PM EDT, 10/02/2024 (MT Newswires) -- Fidelity National Financial ( FNF ) said Wednesday it acquired commercial operations of First Nationwide Title Agency, which is a division of AMT Commercial Title Services and a subsidiary of AmTrust Financial Services. As part of the acquisition, FNTA's key commercial leadership team will join FNF, the company said. ...
Levi Strauss Fiscal Q3 Adjusted Earnings, Net Revenue Rise
Levi Strauss Fiscal Q3 Adjusted Earnings, Net Revenue Rise
Oct 2, 2024
04:34 PM EDT, 10/02/2024 (MT Newswires) -- Levi Strauss (LEVI) reported fiscal Q3 adjusted earnings late Wednesday of $0.33 per diluted share, up from $0.28 a year earlier. Analysts polled by Capital IQ expected $0.31. Net revenue in the quarter ended Aug. 25 rose to $1.52 billion from $1.51 billion a year earlier. Analysts surveyed by Capital IQ expected $1.55...
Copyright 2023-2026 - www.financetom.com All Rights Reserved